Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease?

被引:2
|
作者
Tursi, A. [1 ]
机构
[1] ASL BAT, Gastroenterol Serv, Andria, BT, Italy
关键词
D O I
10.1111/apt.12216
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:752 / 753
页数:2
相关论文
共 50 条
  • [31] Letter: management of post-operative Crohn's disease - thiopurines vs adalimumab
    Aguas, M.
    Nos, P.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (01) : 168 - 169
  • [32] Disseminated Cytomegalovirus Infection in a Patient With Crohn's Disease on Adalimumab Therapy
    Ernstoff, Nathaniel
    Singh, Simi
    Mandell, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S301 - S301
  • [33] Adalimumab in pediatric Crohn's disease
    Patel, Ashish S.
    Suarez, Lisbet D.
    Rosh, Joel R.
    IMMUNOTHERAPY, 2016, 8 (02) : 127 - 133
  • [34] Pharmacokinetics of adalimumab in Crohn's disease
    Ternant, David
    Karmiris, Konstantinos
    Vermeire, Severine
    Desvignes, Celine
    Azzopardi, Nicolas
    Bejan-Angoulvant, Theodora
    van Assche, Gert
    Paintaud, Gilles
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (09) : 1155 - 1157
  • [35] Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease - authors' reply
    Rosen, M. J.
    Minar, P.
    Vinks, A. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (02) : 241 - 241
  • [36] Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease
    Wenger, Sandra
    Nikolaus, Susanna
    Howaldt, Stefanie
    Bokenneyer, Bernd
    Sturm, Andreas
    Preiss, Jan C.
    Schoepfer, Main M.
    Stallnnach, Andreas
    Schmidt, Carsten
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (01): : 21 - 28
  • [37] Adalimumab monotherapy versus combination therapy with adalimumab and immunomodulators for Crohn's disease: A meta-analysis
    Kopylov, U.
    Al-Taweel, T.
    Yaghoobi, M.
    Afif, W.
    Bitton, A.
    Lakatos, P. L.
    Ben-Horin, S.
    Seidman, E. G.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S50 - S51
  • [38] Sarcoidosis During Therapy With Adalimumab in a Crohn's Disease Patient: Consequence of the Therapy or Association With the Disease Itself?
    Kotze, Paulo
    de Barcelos, Ivan
    Abou-Rejaile, Vinicius
    Kotze, Lorete
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S18 - S18
  • [39] Adalimumab Monotherapy Versus Combination Therapy With Adalimumab and Immunomodulators for Crohn's Disease: A Meta-Analysis
    Kopylov, Uri
    Al-Taweel, Talal
    Yaghoobi, Mohammad
    Bitton, Alain
    Lakatos, Peter L.
    Ben-Horin, Shomron
    Seidman, Ernest G.
    Afif, Waqqas
    GASTROENTEROLOGY, 2014, 146 (05) : S201 - S201
  • [40] Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn's disease
    Matar, M.
    Shamir, R.
    Turner, D.
    Broide, E.
    Weiss, B.
    Ledder, O.
    Guz-Mark, A.
    Rinawi, F.
    Cohen, S.
    Olivestone, C. Topf
    Shaul, R.
    Ben-Horin, S.
    Assa, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S578 - S579